News - Inspiration Biopharmaceuticals, North America


Popular Filters

US FDA puts clinical hold on Ipsen and Inspiration's hemophilia drug candidate


There was bad news for French drugmaker Ipsen (Euronext: IPN) and partner privately-held US firm Inspiration…

IB1001Inspiration BiopharmaceuticalsIpsenNorth AmericaPharmaceuticalRegulationResearch

ThromboGenics re-files ocriplasmin BLA and Inspiration submits IB 1001 to FDA


Belgian biopharma company ThromboGenics NV (Euronext Brussels: THR) said this morning that it has resubmitted…

BiotechnologyInspiration BiopharmaceuticalsIpsenNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top